Background
Carbohydrate antigen 19-9 (CA 19-9) is a tumor marker whose level is elevated in many types of cancers and other benign conditions. CA 19-9 levels are frequently found to be elevated in individuals during general health examinations. This study aimed to investigate the clinical characteristics of such individuals and to determine the need for medical follow-up.
Methods
We investigated individuals who underwent a health inspection, including a serum CA 19-9 test, at our center. Their CA 19-9 levels, age, sex, body mass index (BMI), and personal and past histories were investigated. Additionally, subgroup analyses were performed for those who underwent follow-up study for the elevated CA 19-9 levels.
Results
Of 58,498 subjects, 581 (1.0%) had elevated CA 19-9 levels. Multivariate analyses revealed that older age, female sex, lower BMI, and diabetes were independent predisposing factors for elevated CA 19-9 level. A subgroup analysis revealed that the causative conditions were identified in 129 of 351 subjects (36.8%). Among them, the causative conditions in 31 subjects (8.8%, including four cases of cancer and 15 of benign tumors) were not detected at the initial check-up and were found during the follow-up period.
Conclusion
The use of CA 19-9 as a marker for cancer in healthy individuals is inappropriate. However, medical follow-up in individuals with elevated CA 19-9 levels may be useful because some causative diseases may be detected during follow-up.

Citations

• Evolving landscape of detection and targeting miRNA/epigenetics for therapeutic strategies in ovarian cancer
  Arpan Dey Bhowmik, Pallab Shaw, Mohan Shankar Gopinatha Pillai, Geeta Rao, Shailendra Kumar Dhar Dwivedi
  Cancer Letters.2025; 611: 217357.     CrossRef
• Lung Adenocarcinoma Presenting With Elevated Serum Carbohydrate Antigen 19-9 Levels: A Case Report
  Mónica Lopes, Vera Figueiredo, Ana Mendes, Marta Amaral, José Delgado Alves
  Cureus.2025;[Epub]     CrossRef
• A High Performing Biomarker Signature for Detecting Early-Stage Pancreatic Ductal Adenocarcinoma in High-Risk Individuals
  Norma A. Palma, Aimee L. Lucas, Bryson W. Katona, Alcibiade Athanasiou, Natasha M. Kureshi, Lisa Ford, Thomas Keller, Stephen Weber, Ralph Schiess, Thomas King, Diane M. Simeone, Randall Brand
  Cancers.2025; 17(11): 1866.     CrossRef
• Association of Circulating Carbohydrate Antigen 19-9 Level with Type 2 Diabetic Kidney Disease in Chinese Adults: A Cross-Sectional Study
  Pijun Yan, Jia Li, Yi Zhang, Xiaofang Dan, Xian Wu, Xing Zhang, Yuxia Yang, Xiping Chen, Shengxi Li, Pan Chen, Qin Wan, Yong Xu
  Diabetes, Metabolic Syndrome and Obesity.2024; Volume 17: 467.     CrossRef
• Attitudes and health behaviors of middle-aged and older adults with elevated tumor markers in China
  Renke Yu, Zhijie Xu, Yiting Lu, Yue Zhu, Liying Chen
  Frontiers in Psychology.2024;[Epub]     CrossRef
• Prognostic value of serum oncomarkers for patients hospitalized with acute exacerbation of interstitial lung disease
  Cuirong Ba, Chunguo Jiang, Huijuan Wang, Xuhua Shi, Jiawei Jin, Qiuhong Fang
  Therapeutic Advances in Respiratory Disease.2024;[Epub]     CrossRef
• Pancreatic incidentaloma: incidental findings from history towards the era of liquid biopsy
  J-Matthias Löhr, Miroslav Vujasinovic, Nikolaos Kartalis, Philipp Osten
  eGastroenterology.2024; 2(3): e100082.     CrossRef
• Clinical presentation and outcomes of pancreatic cancer at a tertiary care hospital in the sub-Himalayan region: A retrospective observational study
  Amit Gupta, Deepak Rajput, Shyam Karuppusamy Krishnasamy, Oshin Sharma, Rahul Mishra, Amoli Tandon, Sweety Gupta
  Cancer Research, Statistics, and Treatment.2023; 6(1): 44.     CrossRef
• The Association of Carbohydrate Antigen (CA) 19-9 Levels and Low Skeletal Muscle Mass in Healthy Adults
  Jae Hyun Lee, Dong-Kun Kim, Mi-Yeon Lee, Han-Sol Lim, Min-Jung Kwon, Yong-Taek Lee, Kyung Jae Yoon, Chul-Hyun Park
  Nutrients.2023; 15(15): 3394.     CrossRef
• The significance of elevated tumor markers among patients with interstitial lung diseases
  Byoung Soo Kwon, Eun Sun Kim, Sung Yoon Lim, Myung Jin Song, Yeon Wook Kim, Hyung-Jun Kim, Yeon Joo Lee, Jong Sun Park, Young-Jae Cho, Ho Il Yoon, Choon-Taek Lee, Jae Ho Lee
  Scientific Reports.2022;[Epub]     CrossRef
• CA19-9 Level to Serum γ-Glutamyltransferase as a Potential Prognostic Biomarker in Patients with Pancreatic Head Carcinoma
  Shao-Cheng Lyu, Jing Wang, Mengxiu Huang, Han-Xuan Wang, Lin Zhou, Qiang He, Ren Lang
  Cancer Management and Research.2021; Volume 13: 4887.     CrossRef
• Carbohydrate antigen 19-9 as a novel prognostic biomarker in distal cholangiocarcinoma
  Tao Jiang, Shao-Cheng Lyu, Lin Zhou, Jing Wang, Han Li, Qiang He, Ren Lang
  World Journal of Gastrointestinal Surgery.2021; 13(9): 1025.     CrossRef
• Clinicopathological characteristics of gastric cancer with carbohydrate antigen 19‐9 expression occurring in elderly individuals: An autopsy study
  Tan Wang, Yoko Matsuda, Keisuke Nonaka, Mototsune Kakizaki, Toshiyuki Ishiwata, Nobuo Kanazawa, Satoko Uegaki, Masaaki Muramatsu, Motoji Sawabe, Seijiro Mori, Masashi Tanaka, Masanobu Kitagawa, Tomio Arai
  Pathology International.2020; 70(2): 92.     CrossRef
• Challenging biliary strictures: pathophysiological features, differential diagnosis, diagnostic algorithms, and new clinically relevant biomarkers - part 1
  Jean-Marc Dumonceau, Myriam Delhaye, Nicolas Charette, Annarita Farina
  Therapeutic Advances in Gastroenterology.2020;[Epub]     CrossRef
• High Carbohydrate 19-9 Antigen Serum Levels in Patients with Nonmelanoma Skin Cancer and Primary Occult Cancer
  Giulia Malaguarnera, Saverio Latteri, Roberto Madeddu, Vito Emanuele Catania, Gaetano Bertino, Rosario Emanuele Perrotta, Francesco Dinotta, Michele Malaguarnera
  Biomedicines.2020; 8(8): 265.     CrossRef
• Limited usefulness of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for gastrointestinal and whole-body cancer screening
  Masau Sekiguchi, Takahisa Matsuda
  Scientific Reports.2020;[Epub]     CrossRef